Newborn screening by OneDNA helps detect genetic and metabolic disorders early, enabling timely treatment and better long-term health outcomes for your baby.
Newborn screening is a simple, safe heel-prick blood test performed within the first 24–72 hours after birth to detect serious but treatable congenital and metabolic disorders, often before any symptoms appear. The test uses a Dried Blood Spot (DBS) card collected via heel prick and is analysed using advanced technologies including ELISA, TMS, GC-MS, and LC-MSMS at ISO-certified laboratories.